NX Development Corp. is Granted Orphan-Drug Designation Status by US FDA for Gleolan® in Ovarian and Related Cancers
NXDC Logo Logo of NXDC
LEXINGTON, Ky., March 5, 2024 (Newswire.com)
–
NX Development Corp. (NXDC) has achieved another milestone as we proudly announc…
